Florin Zubașcu

In 2013, the growth rate of private R&D investment in Europe fell to 2.9 per cent, due to falling corporate profits and a weak pharma and tech sector

Incremental innovation won’t do, experts say. At stake is leadership in life sciences, transportation, infrastructure and communications technologies

Akvolution’s technology combines two different pre-treatment processes in one, cutting the cost of desalination by 25%

Tibor Navracsics was left with little time to discuss the education portfolio as MEPs questioned him on Hungary’s poor track-record in defending freedom of speech and the rule of law.

Vytenis Andriukaitis pledges to widen access to innovative healthcare across the EU and to keep the highest health and food safety standards in a more equal ‘Health Union’

Winners of European Research Council Proof-of-Concept grants pitched their innovative ideas to investors and stakeholders at a Science|Business Innovation Board event last week.

Poland must break down the silos between academics and industry, to build the trust and infrastructures needed to underpin multilateral collaborations, and enable Polish medical researchers to capitalise on pharma’s thirst for external innovation

The EU-funded BASTION project aims to build relationships between science and industry and promote the translation of cancer research into new treatments. But a number of obstacles must be removed before true collaboration can flourish

The EU-funded BASTION project aims to build relationships between science and industry and promote the translation of cancer research into new treatments. A number of obstacles must be removed before true collaboration can flourish

The voting pattern of Eurosceptic MEPs reveals that radical parties rarely agree on research, technology and innovation policies, as a Science|Business analysis shows